A retrospective evaluation of radiotherapy for the treatment of local esophageal squamous cell carcinoma recurrence after initial complete surgical resection

Journal of Investigative Medicine

Volumn 61, Issue 1, 2013, Pages 34-39

  Zhu, Yu Liang ^a,b   Li, Qun ^b,c   Gao, Jian Ming ^b,c   Li, Ji Shi ^d   He, Zhen Yu ^b,c   Xu, Jun Jie ^b,c   Lu, Xiao Jun ^a   Liu, Yu Meng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b State Key Laboratory of Oncology   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d Twelfth Guangzhou People's Hospital   (China)

Author keywords

Esophageal cancer; Radiation therapy; Recurrence; Recurrent esophageal carcinoma; Squamous cell carcinoma

Indexed keywords

BLEOMYCIN; CAPECITABINE; CISPLATIN; DOCETAXEL; FLUOROURACIL; NEDAPLATIN; PACLITAXEL;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISTANT METASTASIS; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN; TREATMENT FAILURE;

EID: 84873652035     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e318276de92     Document Type: Article

References (21)

1. TM Version 2.2011 for Esophageal and Esophagogastric Junction Cancers. 2011. Available at: http://www.nccn.org/ professionals/physician-gls/pdf/esophageal.pdf. Accessed October 3, 2011.
2. Tang Z. Modern Oncology. 9th ed. Shanghai, China: Fudan University Press; 2005.
3. Bhansali MS, Fujita H, Kakegawa T, et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg. 1997;21:275-281.
4. Collard JM, Otte JB, Reynaert MS, et al. Extensive lymph node clearance for cancer of the esophagus or cardia: merits and limits in reference to 5-year absolute survival. Hepatogastroenterology. 1995;42:619-627.
5. Tam PC, Siu KF, Cheung HC, et al. Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg. 1987;205:189-194.
6. Gockel I, Sgourakis G, Lyros O, et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384.
7. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-232.
8. Zhang HL, Liu RL, Shi YT, et al. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer]. Zhonghua Zhong Liu Za Zhi. 2009;31:541-545.
9. Stahl M, Oliveira J. Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(suppl 4):32-33.
10. Baxi SH, Burmeister B, Harvey JA, et al. Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imaging Radiat Oncol. 2008;52:583-587.
11. Gao XS. Considerations of treatment standardization from the procession of NCCN guideline of esophageal cancer. Chin J Cancer. 2010;29:860-864.
12. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-2084.
13. Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616-1623.
14. Hsu PK, Wang BY, Huang CS, et al. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558-565.
15. Natsugoe S, Okumura H, Matsumoto M, et al. The role of salvage surgery for recurrence of esophageal squamous cell cancer. Eur J Surg Oncol. 2006;32:544-547.
16. Nemoto K, Ariga H, Kakuto Y, et al. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol. 2001;61:165-168.
17. Shioyama Y, Nakamura K, Ohga S, et al. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol. 2007;37:918-923.
18. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729-735.
19. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989;63:1912-1917.
20. James RD, Johnson RJ, Eddleston B, et al. Prognostic factors in locally recurrent rectal carcinoma treated by radiotherapy. Br J Surg. 1983;70:469-472.
21. Yang TS, Ng KT, Wang HM, et al. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma Va retrospective review of 182 cases. Am J Clin Oncol. 1996;19:337-343.